Brief: Matinas BioPharma Enters Into At-The-Market Sales Agreement With BTIG
02/07/2020 22:15
July 2 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA - ON JULY 2, ENTERED INTO AT-THE-MARKET
SALES
AGREEMENT WITH BTIG, LLC
* MATINAS BIOPHARMA - UNDER SALES AGREEMENT CO MAY OFFER AND
SELL,
SHARES OF COMMON STOCK OF UP TO $50 MILLION
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: GH Power Signs Multi-Year Hydrogen Offtake Agreement With Change Energy For Hamilton Facility Output
Brief: Gh Power And Tkms Continue To Explore Clean Energy Collaboration In Support Of Canada’S Future Patrol Submarine Project
Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
Brief: Matinas Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards And Acceptance Of Plan To Regain Compliance
Brief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing